Last month, a letter dropped onto Robert Jones doormat containing just about the best possible news.
It revealed the person he had donated bone marrow to was doing very well, two years on from a life-saving blood stem cell transplant.
The Pontypridd hooker doesnt know much about the recipient, other than hes a 24-year-old young man from Ireland.
But with two years having passed, that person will now receive details of his donor and can get in touch with him and meet up if he so wishes.
Its a meeting Jones would love to see take place.
He has decided to talk about what he did and the happy outcome in order to encourage more people to join the donor list.
So how did it all come about?
I have given blood for about 10, 12 years now, he explained.
Then about four years ago, the Welsh Blood Service just asked me if I would mind going on the bone marrow donor list.
I lost my grandfather, Howard, to leukaemia six years ago. So as soon as they said it could benefit people who suffer with blood cancer, I couldn't say no, really.
I joined the register and they just took an extra sample of blood to test.
I didnt expect to hear anything, but within a year and a half, Welsh Blood contacted me to say they had a potential match. I was a bit shell-shocked.
I went down and had a discussion with them. I didnt know anything about who I was going to be donating to at that point.
I went for a medical, a full body MOT to make sure I was fit enough.
With that box ticked, it was then a question of deciding which procedure to go for.
They give you two options, he explained.
Either a stem cell transplant where you are hooked up to a machine for 12 hours or taking the bone marrow, which involves drilling into your hip bone.
I went for the drilling one.
In simple terms, the stem cell is quantity over quality, whereas the bone marrow is quality over quantity.
When I had my meetings with Welsh Blood to make my choice, they said it was a 22-year-old young boy from Ireland who had leukaemia.
At the time, my brother was 23, 24 and I just thought imagine that was my brother.
The only thing I could think of was imagine the shoe was on the other foot and it was one of my family members or friends suffering.
Plus the idea of being hooked up to a machine for 12 hours straight would have skulled me to death!
So I went for the bone marrow option. It was more likely to be helpful and useful.
That was in January 2018. When you hear exactly what the procedure involved, you have nothing but admiration for Jones.
They drill straight into your hip bones to the core and then they withdraw your whole bone marrow, he said.
There were six drill holes right in the bottom of my back. It depends on the individual, the amount of marrow they take.
If theres enough to take, they keep taking it really. The nurse said they took a hell of lot more from me than a normal person, possibly because I am so big!
I think it was 600 mill they had out of me.
The operation lasted about three hours in all.
I woke up from the anaesthetic about 1pm in the afternoon and I was in so much pain I said put me straight back under!
It was such a severe ache I just couldnt ignore it. So they put more morphine in and I went straight back to sleep.
Then I woke up about 6pm and my mother was there to pick me up.
She said I just looked horrendous, as white as a ghost.
But I went home that evening, so I was in and out of hospital in the day.
I couldnt sit down for a week. I had to lie flat. So I was more or less settee or bed bound.
Obviously I was in a lot of pain and I was off work for three or four months. They were really supportive.
I was still aching for up to a year, but not to the extent as when I woke up.
Jones, who works as an area manager for Wales & West Utilities gas distribution network, obviously had a break from rugby while he recovered - although not for too long.
He was with Cross Keys at the time, having joined them following a seven-year stint with his hometown club Treorchy, for whom he played more than 200 games.
One of the big questions I asked was whether it would prevent me playing rugby, but they said it would have no long-lasting effect, he said.
I was back training after about eight weeks and played my first game after around four months, towards the end of the season.
For about a year, every time I was having scrummaging sessions or a game, the bottom of my back was just aching.
I am a hooker, so I am right in the mix of it. The second rows were pushing right on the sore spot at the bottom of my spine.
"I'm over all that now and fortunately I am still able to play, but even if it had been the end of my rugby career, that's nothing to me really.
"I've still got my good health and I'm fortunate to be still here, with all my friends and family, and that young man wouldn't be, so I have no regrets at all and if I could do it again tomorrow, I would."
A year on from his procedure, Jones received notification the recipient had survived the transplant and last month there was an even more positive update.
The letter from Welsh Blood said the young man from Ireland was very well and had not suffered any major complications.
That makes it all worthwhile, said Jones.
Its very rewarding.
And it also raises the possibility of donor and recipient meeting up.
After two years, they get all my information, so they can contact me, he said.
If he wants to get in touch with me, I would love to hear from him, just to see how he is and meet him possibly. That would be phenomenal.
I am open to the idea of getting to know him, but obviously its totally down to the individual.
Now 29, Jones is in his second season with Pontypridd having switched to Sardis Road after two years with Cross Keys.
Im loving it there. They are a really great bunch of boys, he said.
Hes currently sidelined with a hamstring problem, but understandably such issues are pretty minor in the general scheme of things when you have been through the kind of experience he has.
Ask him whether he would do it all again if he had his time over, and he provides an emphatic answer.
100 per cent. I would do it again tomorrow, he said.
I have given that person at least two years extra.
The bone marrow is the last straw. If he hadnt had that, he probably wouldnt have been around today.
"So no regrets at all. You just give someone that little hope and I would definitely encourage people to think about going on the register.
See the original post here:
The selfless act of popular Welsh rugby player who risked his career to save the life of a stranger - Wales Online
- UC Irvine Study Reveals Risks Associated with Direct-to-Consumer Ads for Stem Cell and Exosome COVID-19 Therapies - India Education Diary - November 18th, 2023
- STEM | Description, Development, & Facts | Britannica - January 31st, 2023
- What is STEM Education? | Live Science - January 31st, 2023
- Science, Technology, Engineering, and Math, including Computer Science - ed - January 23rd, 2023
- What Does STEM Stand For? Definition, Degrees and More - January 23rd, 2023
- What Is STEM? - Definition & Resources for Teachers - January 23rd, 2023
- Science, technology, engineering, and mathematics - Wikipedia - January 23rd, 2023
- Stem Definition & Meaning - Merriam-Webster - January 23rd, 2023
- November: labblood-study | News and features - University of Bristol - November 7th, 2022
- Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem, a Novel Cell Therapy for the... - November 7th, 2022
- Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and... - November 7th, 2022
- Type 2 Diabetes Stem Cell Therapy - Top U.S. Stem Cell ... - January 1st, 2022
- Cancer Drug Approvals from 2021 That Patients May Have Missed - Curetoday.com - January 1st, 2022
- Late effects in survivors of high-risk neuroblastoma following stem cell transplant with and without total body irradiation - DocWire News - January 1st, 2022
- The new life of a teenager with a strange tumor on his face after the operation - Market Research Telecast - January 1st, 2022
- Best of what was new in diabetes health for 2021 - Dickson Post - January 1st, 2022
- Hematopoietic Stem Cell Transplantation - StatPearls ... - December 22nd, 2021
- Autologous Stem Cell Transplant for Multiple Myeloma - December 22nd, 2021
- City of Hope presents leading-edge research on blood cancer therapies and its vaccine to reduce stem cell transplant complications at American Society... - December 22nd, 2021
- Adaptation Is Key to Advancing Care for Adult Patients With Leukemia - OncLive - December 22nd, 2021
- FDA Approves First Drug to Prevent Graft Versus Host Disease | FDA - FDA.gov - December 22nd, 2021
- Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients - Yahoo Finance - December 22nd, 2021
- After throwing goodbye party, woman with cancer finds hope close to home in Austin - Austin American-Statesman - December 22nd, 2021
- Dr. K.M. Cherian Heart Foundation & Educational Society Organized Cme Programme & Workshop On Cell Culture And Regenerative Medicine - APN... - December 22nd, 2021
- Namesake of new center a young man in love with the pursuit of knowledge - The Saint Anselm Crier - November 7th, 2021
- Red Cross blood drive focuses on sickle cell disease fight - Palladium-Item - November 7th, 2021
- Shockwave therapy brings new healing opportunities for heart attack patients and hope for people with spinal cord injuries - KULR-TV - November 7th, 2021
- 1st CRISPR Gene Editing Trial Slated to Open in Severe SCD Patients - Sickle Cell Anemia News - April 4th, 2021
- Transplant After CD19 CAR T-Cell Therapy Shows Durable Disease Control in Children, Young Adults With B-ALL - Cancer Network - April 4th, 2021
- Timely Bone Marrow Transplant by Fortis gives new lease of life to a patient with Multiple Myeloma - APN News - April 4th, 2021
- Kirron Kher is suffering with Multiple Myeloma: Know the causes, symptoms and more about this type of blood cancer - Jagran English - April 4th, 2021
- Decitabine Improved Outcomes for Patients With Refractory Prolonged Isolated Thrombocytopenia - Hematology Advisor - April 4th, 2021
- Lake in the Hills police officer and father of 4 kids battling rare cancer forced to retire - Lake and McHenry County Scanner - April 4th, 2021
- Insulin 100: How the road to a diabetes cure is yielding better treatments - News@UofT - April 4th, 2021
- Boxcar Scars Market |Exclusive Report on Latest Trends and Market Growth Opportunities - BioSpace - April 4th, 2021
- Merck Receives Positive EU CHMP Opinion for Updated Label of KEYTRUDA (pembrolizumab) To Include Results of Phase 3 KEYNOTE-361 Trial in Certain Adult... - April 4th, 2021
- BeyondSpring Announces Submission of New Drug Application to US FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of... - April 4th, 2021
- Types of leukemia: Prevalence, treatment options, and prognosis - Medical News Today - February 14th, 2021
- Roche receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients -... - February 14th, 2021
- Energy drinks may damage the heart, researchers warnshould the FDA get involved? - Cardiovascular Business - February 14th, 2021
- FDA Approves G1 Therapeutics' COSELA (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced... - February 14th, 2021
- Easter Ross mum of blood cancer tot urges would-be stem cell donors to show the love this Valentine's Day; Alness lass Adeline Davidson's plight... - February 14th, 2021
- Global Induced Pluripotent Market Positive Outlook, Revenue Generation & Leading Manufacturers, Forecast 2026||CELGENE CORPORATION; Astellas... - February 14th, 2021
- Leukemia in children: Symptoms, causes, treatment, outlook, and more - Medical News Today - February 7th, 2021
- After Bone Marrow Donation Saves 9-Year-Old Boy With Cancer, Boston Mom Fights To Raise Awareness - Here And Now - February 7th, 2021
- Understanding bone marrow transplant: The guidelines and the protocols - The New Indian Express - February 4th, 2021
- Why Cynata is hopeful its COVID treatment trial will succeed where others have failed - Business News Australia - February 4th, 2021
- Mobilize family caregivers to speed the rollout of Covid-19 vaccines - STAT - February 4th, 2021
- People With Cancer Should Receive COVID-19 Vaccine, Experts Say - Cancer Health Treatment News - February 4th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy f - PharmiWeb.com - February 4th, 2021
- APOE Tied to Increased Susceptibility to SARS-CoV-2 | ALZFORUM - Alzforum - February 4th, 2021
- Transforming Outcomes in Advanced CSCC with Immunotherapy - LWW Journals - February 4th, 2021
- Ashley Cain is living his worst nightmare as his baby daughter battles leukaemia in hospital - The Sun - February 4th, 2021
- Canada's blood supply has a diversity problem and people are dying because of it - CBC.ca - February 1st, 2021
- Autologous Stem Cell and Non Stem Based therapies Market Share, Size 2021 Global Industry Future Trends, Growth, Strategies,, Segmentation, In-depth... - February 1st, 2021
- Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA (pembrolizumab) in Certain Patients With Relapsed or Refractory Classical... - February 1st, 2021
- Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA (pembrolizumab) in Combination With Ipilimumab Versus KEYTRUDA... - February 1st, 2021
- Disabled People Are Waiting, Anxiously, For Lifesaving Covid-19 Vaccinations - Forbes - February 1st, 2021
- Family of Belfast woman Eimear Gooderham (25) share memories and dealing with grief in special UTV programme - Belfast Telegraph - February 1st, 2021
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation - Science Advances - February 1st, 2021
- The Need for New Biological Targets for Therapeutic Intervention in COPD - Pulmonology Advisor - February 1st, 2021
- What Patients With Cancer, Survivors Need to Know About the Emergency Use Authorization of COVID-19 Vaccine - Curetoday.com - December 19th, 2020
- Every Patient Treated With CRISPR Gene Therapy for Blood Diseases Continues to Thrive, More Than a Year On - Good News Network - December 19th, 2020
- Are Hiccups a Sign of the New Coronavirus? - Healthline - December 19th, 2020
- KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective... - December 19th, 2020
- Covid-19 can have impact on heart too, say experts - Hindustan Times - December 19th, 2020
- Even if You've Had COVID-19 You Still Need the Vaccine - Healthline - December 19th, 2020
- The Link Between Cancer and Metabolic Dysfunction - Technology Networks - December 19th, 2020
- Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes -... - December 19th, 2020
- Gene therapy gives man with sickle cell disease the chance for a better future - Science Codex - December 3rd, 2020
- Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous... - December 3rd, 2020
- Coronavirus Updates: The Latest Treatments and Vaccines - GovTech - December 3rd, 2020
- Graft Versus Host Disease (GVHD) Patient Population, Treatment Algorithm, Medical Practices And Epidemiology Forecast To 2030 - The Market Feed - December 3rd, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - India Education Diary - December 3rd, 2020
- Coinfection: more than the sum of its parts - Science Codex - November 19th, 2020
- Angiocrine Bioscience Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to AB-205 (Universal E-CEL Cell Therapy) to... - November 17th, 2020
- FDA Approves Merck's KEYTRUDA in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple?Negative Breast... - November 17th, 2020
- Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection - DocWire News - November 17th, 2020
- Cleveland Clinic team draws a link between COVID-19 protection and the sleep aid melatonin - FierceBiotech - November 17th, 2020
- UH announces participation in clinical trial testing antibodies to treat COVID-19 in adults - News 5 Cleveland - November 7th, 2020